Rapid Rx Quiz: COVID Treatments

Mary L. Windle, PharmD


March 01, 2022

Coadministration of remdesivir with chloroquine or hydroxychloroquine is not recommended. On the basis of in vitro data, chloroquine demonstrated an antagonistic effect on the intracellular metabolic activation and antiviral activity of remdesivir. An EUA for chloroquine or hydroxychloroquine was issued for by the FDA in March 2020 and was revoked in June 2020, owing to safety concerns and lack of efficacy demonstrated in controlled clinical trials. 

Learn more about remdesivir here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.